FinancialPress releases
Year-end Report (Q4) July 2023 – June 2024
Related documents
Recent Posts
Related Posts
Press releases
Immunterapi som behandling av återkommande urinvägsinfektioner – nu tre framgångsrika Fas II-studier i Hamlet BioPharma
Hamlet BiopharmaOctober 8, 2024
Press releases
Hamlet BioPharmas digitala investerarmöte tidigareläggs till den 9 oktober kl. 12:00 CET
Hamlet BiopharmaOctober 1, 2024
Press releases
Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics
Hamlet BiopharmaSeptember 26, 2024